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Fourteen adult patients with chronic atopic dermatitis and 
active skin lesions had a skin biopsy and venous blood 
sample taken on the same day. Absolute numbers of 
circulating lymphocytes were normal in all patients. Fluo-
rescence-activated cell sorter (FACS) analysis revealed nor-
mal numbers of total T lymphocytes and T -helper and T-
suppressor subsets (helper: suppressor ratio, 2: 1) in the 
atopic patients' peripheral blood, but an increase in circulat-
ing B lymphocytes and in HLA-D-related antigen-bearing 
M ultiple immunologic abnormalities have been re-ported in patients with atopic dermatitis . These have been well summarized by Hanifin [1 ,2] . Some of these abnormalities are seen only tran-siently when the skin is acutely inflamed. One 
of the more commonly reported abnormalities is an alteration in 
the numbers of circulating T lymphocytes. A deficiency in both 
the total T cells, as measured by E-rosette formation [3-5], and 
numbers of T -suppressor cells, as measured by either the Fc re-
ceptor [5-8] or by using a monoclonal marker such as OKT8, 
has been reported (7,9-13]. However, not all studies have re-
corded similar changes, and some were unable to demonstrate 
any abnormali ty in either T -suppressor cell numbers or function 
[14-16]. 
Histologic examination of the skin of patients with atopic der-
matitis (AD) has revealed a dermal lymphocytic infiltrate [17,18] 
that was shown to be composed predominantly ofT lymphocytes 
[19]. This infiltrate was later phenotypically identified as T -helper 
lymphocytes [20,21] . It is difficlllt to interpret the significance of 
this cutaneous infiltrate without knowledge of the absolute I1lIlTI-
bers and relative proportions of T-cell subsets in a concnrrent 
blood sample, and we therefore decided to examine the numbers 
of T lymphocytes and subsets in both the skin and peripheral 
blood in the same patients on the same day. 
Manuscript received May 5, 1986; accepted for publication October 22, 
1986. 
This study received financial support from the National Eczema Society 
and from the Greater Glasgow Health Board Research Support Group . 
Reprints not ava ilable. 
Correspondence: Dr. Rosemary Lever, Department of Dermatology, 
Western Infirmary, Glasgow, U.K. Gl1 6N T 
Abbreviations: 
AD: atopic dermatitis 
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cells. The skin biopsy showed a dermal infil tra te of predomi-
nantlyT -helperlymphocytes (helper: suppressor ratio, 7: 1). 
These cells showed strong HLA-DR plasma membrane 
staining. There was no HLA-DR staining in the membranes 
of epidermal keratinocytes. Using a monoclonal antihuman 
IgE, positive staining was observed in the dermis, though 
none was identified in the epidermis. The dermal anti-lgE 
staining was concentrated around clusters of T lympho-
cytes. ] Invest Dermatol 89:4-7, 1987 
An elevated total serum IgE is seen in 80% of patients with 
AD, and positive prick tests , presumably due . to tissue-bound 
IgE, are also found in a similar number of patients. Because of 
this, we looked for the presence of IgE staining in the skin and 
subsequently used double-staining immunoperoxidase techniques 
to determine its association with cells in the dermal 'infiltrate . 
MATERIALS AND METHODS 
Fourteen adults (6 men, 8 women), aged 18-47 years (mean 27.2 
years) gave their informed consent. All patients had classic chron-
ically relapsing AD w ith recurrent severe flares. To enable the 
necessary coordination of the project, patients were generally 
studied in a chronicall y active state requiring moderate-strength 
topical steroids such as c1obetasone butyrate (0.05%) rather than 
in an acute flare, with 1 exception. Other diagnostic criteria in-
cluded: onset of dermatitis when the patient was under 5 years 
old (13 patients, 93%); personal history of other atopic disease 
(13 patients, 93%); a positive fam ily history of atopy (10 patients, 
71 %). In addition, 12 patients had either an elevated IgE, positive 
RAST tests, or positive prick tests . The study was approved by 
the hospital ethi cs committee. 
An elliptical skin biopsy was taken from the most active area, 
excluding the face, and a venous blood sample withdrawn from 
all patients between 9 and 11 A.M. in order to minimize any 
variation in the lymphocyte subsets due to the circadian rhythm. 
Four milliliters of the venous sample was taken into a seques-
trene bottle for a standard full blood count by Coulter analysis , 
and the remainder placed in heparinized containers (Evans bottles, 
Speke, Liverpool, U .K,) . A similar blood sample was taken from 
age- and sex-matched controls with no personal or family history 
of atopy. The mononuclear cells from both patients and controls 
were sepa rated using a Ficoll gradient (Lymphoprep, Nyegaard, 
Oslo, N orway) and were centrifuged at room temperature for 30 
min at 400 g. The mononuclear cells (MN C) were then harvested, 
washed 3 times in RPMI (Gibco, Paisley, Scotland), resuspended 
in a known volume, and counted. The yield ofMNC was checked 
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Table I. U se of Monoclonal Antibodies 
Antibody 
Antigen 
Pan T cc ll 
Helper T ce ll 
Skin 




Suppressor-cytotoxic T cell OKTS 
Regulatory T ce ll 
B ce ll 
HLA-DR antigcn 






















Langerh ans ce lls 
19E 
lnterleukin 2 (IL-2) 
receptor 
Transfcrrin receptor 
Anti-lgE (New England Nucl~a r) 
Anti human IL-2 (Bccton-
Dickinson) 
O KTY 
Most of th e anti bod ies were obtained commerciall y: O KT series-O rrho. High 
Wycombe. Bucks. U.K .. Leu series-Becton-Dickinson. Lab lm pex. Middlesex. 
U.K.; UC HT series-Unipath. Bedford. U.K.; T he Ia 23 1 was kind ly provided 
by Dr. V. vO n Heynin gen. Edinblll'gh. U . K. 
"Nal 34-T his antibod y stains identica l numbers of Lange rh ans cells as OKT6 
and Leu-6 1221. 
on 22 specimens and was found to vary from 46-65. 9% (mean 
53.5% ) for th e atopic patients and 33.3- 64% (mea n 51.3%) fo r 
the controls. Mononuclea r cells (0.5 x 10(,) were then in cubated 
w ith 3 JLl of each of th e monoclonal antibodies (Tab le I) [22] at 
4°C for 30 min: T he cells were then washed twice and incubated 
w ith F(abh for a furth er 30 min at 4°C. The MN C were then 
rewashed twice and res uspended in 1 % para formaldehyde. The 
cells were counted on a fluorescence-activated cell sorter (FACS) 
4 autoanalyser (Becton-Dickinson) . All tes ts were done in du-
plicate . 
The skin biopsy was divided into two. Half was placed into 
5% formol sa line, processed in the usual way , and stained wi th 
H & E for ro utin e histo logic exa mination . T he other half was 
snap-frozen for immunocytochemistry and sections cut at 5 JLm . 
These were stained by the indirect immuno pero xidase technique 
using the monoclonal antibodies shown in T able I. Leu-8 was 
used to stain the reg ul atory T cell [23] and Leu-11 and Leu-7 for 
the natural killer (NK) cells [24,25] . Additional antibodies were 
used exclusively in the skin (see Tab le J) . A doubl e-staining im-
munoperoxidase techniqu e was also used in which the first an-
tibody was labeled in the usual way using the indirect peroxidase 
method , th e section was then relabeled w ith a second an tibody 
fo llowed by an alkaline phos phatase co mplex (APAAP-Dako) 
revealed by incubation w ith naptho l AS-MX (Sig ma) and Fas t 
Blue BB salts [26]. 
Statistical analysis was by un pa ired Student's I-tes t. 
Table II. Full B lood Count-Coulter Counter Res ults 
Hemoglobin (g/d l) 
White cell count (x 109)/L 
% Lymphocytes 
Total lymphocytes (x 10")/L 
Platelets ( x IO")/ L 
Normal 
(n = 16) 
13.S :t 0.3 
6.3 :t 0.5 
32. 1 ± 2.2 
2.0 :t 0. 1 
272 :t 16.3 
Atopic Dermatitis 
(n = 14) 
13. S ± 0.4 
6.5 :t 0.5 
29. 1 ± 1.7 
1. 9 :t 0.2 
310 ± 23.2 
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Table III. Fluo rescence-A ctivated Cell Sorter (FACS) 
Analys is Results 
Lymphocytes 





Natural ki ller-Lcu-7 
Normal 
66.4 ± 2.4( 16) 
43 .4 :t 2.5 (17) 
19.7 ± 0.9 (17) 
3.9 :t 0.4 (12) 
6.3 :t 0.7 (17) 
9.S :t 2.0 (7) 
AtOpi c Dermatitis 
66 .5 ± 3.3 (13) 
43.6 ± 2.9 (14) 
20.6:t 1.2 (14) 
-Leu-II 
Regulatory T cell (Lcu-S) 
I J.l ± 1. 0 (16) 
54.5 :t 3.7 (12) 
6.3 ± 0.7 (12)" 
9.9 ± 0.9 (14)1. 
10.0 ± 1. 5 (S) 
10.S ± 2.0 (13) 
54.4 ± 2.6 (9) 
Ites ul,s give th e percentage of cells labeled with each anti body. Numbers in 
parentheses rcpresellt the number of p:lticllts/ coll tro ls in c:lch g ro up . 
"1' < (l.O I. 
/'1' < O.DO ! . 
RESULTS 
T o tal serum IgE levels were elevated in 12 of 14 patients with 
AD (> 1000 lU / ml in 7 and 550- 950 lU / ml in 5). All contro l 
subj ects had total serum IgE levels in the no rm al range, and 14 
of the 15 had values under 30 1U / ml. The results of the Coulter 
ana lys is (Table II) showed no abnormality in the peripheral blood 
of A D patients by comparison w ith age- and sex-matched control 
subj ects. In particular, there was no evidence of a to tal lymp ho-
penia in the patients with AD. 
T he results o f the FACS analys is are shown in Table 1I1. There 
was no difference in to tal T-lymphocyte numbers, in absolute 
numbers or ratio of helper and suppressor T cells (helper : suppressor 
ratio, 2: I ) or in reg ul ato ry T cells (Leu-8) between the patients 
w ith A D and th e no rmal controls. In the patients w ith AD there 
w as, however, a statistica ll y signifi ca nt increase in the percentage 
numbers of circul ating B cells (AD patients 6.3%, controls 3 .9%; 
p = 0.01) and in the numbers of HLA-DR antigen-bearin g cells 
(AD patients 9.9% , controls 6.3%; p < 0.001) . T he numbers of 
HLA-DR antigen-bea rin g cells in bo th patients and contro ls were 
hi gher than numbers of cells stained by B l or Leu-1 2, ind ica ting 
th at not all were B lymphocytes. When the antibod y Leu-7 was 
used as a m arker of NK cells, the num bers of th ese cells appeared 
to be red uced in patients compared with the controls but this 
difference did not reach statisti cal signifi ca nce. In contras t, when 
Leu-II was used , no difference was seen between numbers of 
circulating NK cells in patien ts with AD and the controls. 
T he results of the immunoperoxidase sta ining of th e skjn are 
summarized in T able IV. T he dermal in ftl trate was composed 
predominan tl y of T -helper cells (Fig 1) and these w ere strongly 
HLA-DR anti gen-positi ve. Relatively few T suppressor-cyto-
toxic cell s were present in the in fi ltrate and the helper : suppresso r 
ratio was 7 : 1. In contrast to a number of o th er chroni c inflam-
m atory skin diseases w ith a lymphoid infiltrate such as allerg ic 






T ransfcrr in-O KT9 
HLA-DR-dermis 
B ce lls 
NK ce lls 
IgE 
-epidermis 









No positive keratinocytcs 
Occasional positi ve onl y 
Occasional positivc onl y 
13/ 14 patients positi ve dermal stainin g 










Ly mph ocytes arc expressed :lS :l pero:llt:lge of rhe dcrll1:l 1 infilt r:lrc. L:lIl gc rh:lll s 
cells arc counted over 200 basa l cel ls. 
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Figure 1. Double-sta ining irnmulloperox idasc techniquc, illustrating th c 
presence of T-helper ce lls (brown stainin g) and blue sta inin g in dica ting 
the presence of IgE, which is seen mainl y on the surface of a cl uster of 
cells to the right of the illustration. 
contact dermatitis, li chen planus, and m ycosis fungoides, no HLA-
D R antigen-s tained epiderm al keratin ocy tes were seen , alth ough 
Langerh ans cells were cl ea rl y stained . Numbers of epiderm al 
La ngerhans cell s were in creased, w ith a range of25-58 cell s (mea n 
36.5) overl ying 200 basal cells (no rm al range in o ur laborato ry is 
20- 30) 127]. Very few cells in either the epidermis o r dermis 
showed positive staining w ith either Leu-1 2 (B cell ) o r Leu-11 b 
(NK cell) . Cell s bearin g the interleukin 2(IL-2) recepto r we re 
fo und in all sa m ples exa min ed alth o ug h onl y in sm all numbers. 
Posit ive IgE stainin g was seen in th e dermi s in 13 of th e 14 
pat ients . T he 1 pati ent w ho did no t show pos iti ve IgE staining 
had bo th a no rmal to tal serum IgE and a negati ve RA ST screen . 
U sing a dou ble- stainin g technique, th e IgE was m ainl y seen in 
associatio n w ith clusters o f T lymphocytes in th e dermis. N o IgE 
stainin g was seen on the epiderma l Langerh ans cells no r on th e 
dendri t ic cells in the demus. 
D ISCU SSIO N 
It is poss ible th at th e observed in crease in B- cell nu m bers in th e 
peri pheral blood may be responsibl e fo r th e in creased level of 
serum IgE th at is seen in patients w ith AD. O ur findin gs w ith 
rega rd to T ce lls are at variance w ith a number of repo rts of a 
reduction in num bers o r fun cti on of T supp resso r cell s. Som e of 
these reports used the Fc recepto r as a m arker o f suppressor ce lls 
and , as it is recogni zed th at Fc cell s and O KT8 cell s do no t m ark 
identica l populati o ns, o ur p resent repo rt is no t st ri ctl y co m pa rable 
w ith such studies . 
T here arc two possible ca uses of th e o bserved differen ces be-
tween o ur stu dy an d those th at also used O KT8 as a suppresso r-
cell m arker. Firs t, in 2 of th e studi es th e low suppressor cell 
numbers repo rted were in children . Whereas redu ced suppresso r. 
ce ll s m ay be a fea ture of AD in children , in neither o f these 2 
stu dies we re the controls age-matched. In the first , patients had 
a m ean age of 9 and cont rol subj ects a m ean age o f 17 [9]. In th e 
second, the m ea n age o f th e patients w as 5. 5 yea rs and th e co nt ro ls 
32 yea rs [1 0]. A second possible explanati on m ay Jie in diffe rences 
in th e cl inica l ac tiv ity o f the disease w ith redu ced numbers of 
circul atin g suppressor cell s seen onl y in m ore acute phases of AD 
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ac ti vity. In general , the pati ents we exa mined had disease in a 
chroni ca ll y acti ve stage rather th an in acu te Aare, but the 1 pati ent 
in acute Aare had th e lowest number of circul atin g suppresso r 
cell s (15.5% vs our m ea n of 20.6% in thi s st ud y) . O ur results 
fo r the qu antitati ve analys is o f NK cells va ry w ith th e antibod y 
used (Leu-7 o r Leu- 11 ). Patients w ith ato pi c derm atitis are rec-
ogni zed to have redu ced N K cell fun ction 128,291. Leu-ll is sa id 
to " bette r" defin e NK cell s than Leu-7 124]. If thi s is accurate, it 
wo uld im pl y that the redu cti on in N K act ivity in patients w ith 
A D is d ue to a fun cti o nal defect ex pressed by a no rm al number 
of NK ce lls. 
O u.r stu dy confirms previo us repo rts th at the derm al in fi ltrate 
in atopic derm atitis is predo minantl y com posed o fT-h elper ce ll s 
130 1 and that m any o f th ese cell s ex press HLA-D R antigen [21] . 
The rati o of T - helper to T-suppresso r-cyto tox ic cell s o bse rved 
in the de rm al inftltrate was 7: 1, co mpared w ith th e 2: 1 ratio seen 
in the peripheral blood , impl yin g a se lecti ve sequ es trati o n of T -
helper lymphocy tes in the derm al infiltrate. T his is in contras t to 
th e fi nd in gs in acute co ntact derm atitis w herein the derm al in-
filtrate also shows the sa m e 2 : 1 helper: suppressor ra tio as th at 
seen in the pel'ipheral blood [31]. In contrast to studi es o n allerg ic 
conta ct derm ati tis, we saw no la stJ inin g of epiderm J I keratin o-
cy tes in biops ies of ato pi c skin . An in crease in numbers of epi-
derm al Lan ge rhan s ce ll s in th e skin of pat ients w ith AD has been 
repo rted prev io usly 120 1. A recent stud y has repo rted IgE staining 
on epide rm al dend ri t ic ce ll s shown to be Langerh ans cells, bo th 
by do ub le stainin g w ith anti-l gE and O KT6 and by immun ogold 
ultras tru ctural techni ques 132 1. We did no t o bser ve any epiderm al 
IgE stainin g in our patien ts . . 
O ur o bser va ti on o f a spati al rel ati onshi p between derm al IgE 
stainin g and T-helper lymphocy tes m ay be due to the fac t they 
these are T lymphocytes th at bea r the epsilo n receptor 133]. w hich 
co uld be in vo lved in m o dul atin g the response to IgE. T ly m-
phocy tes J re kn own to pro du ce so luble IgE bindin g fac to rs [341 . 
N o direct rcl ati on o f derm al dendriti c ce lls was seen in relatio n 
to th e IgE, alth oug h an indirect associati on m ay ex ist w ith the T 
ly mph ocy tes rela tin g to bo th the IgE and the dendriti c cells in 
th e dermis. The fin d in gs in this stu dy suggest a possible link 
between th e well- recogni zed but as ye t un ex pl ained coexistence 
of type I IgE-medi ated and type IV delayed hy persensiti v ity ab-
no rm aliti es in pati ents w ith AD . 
ADDENDUM 
T his stud y showed that the derm al infiltrate in ato pi c derm atitis 
has the predo mi na nt pheno ty pe o f Leu 3 + 8 - (inducers o f h elp). 
Leu 8 stained o nl y 21 % of th e cell s in stead of the ex pected 60-
70% . T his is in con tras t w ith recent results in all ergic contac t 
derm atitis w here the in filt ra tin g cell was predo min antl y Leu 3 + 8 + 
(inducers of su ppress ion). W ood GS, Vo lterra A S, Abel EA , 
Ni ckolo ff BJ , Ad am s RM: All erg ic contact dermatitis: novel im-
muno histo logic fea tures. J In ves t D erm ato l 87 :688- 693, 1986. 
We .~ rat ~fi '{l )' nclmo lVlc~Qc Dnko, Ltrl. , ElIglnlld jar nVsorbillg the cost of thc 
color prillt . 
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